199 related articles for article (PubMed ID: 15491687)
1. Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer.
Pruthi RS; Derksen E; Gaston K; Wallen EM
Urology; 2004 Oct; 64(4):637-42. PubMed ID: 15491687
[No Abstract] [Full Text] [Related]
2. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection.
Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y
Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678
[TBL] [Abstract][Full Text] [Related]
3. [Cylooxgenase-2: a novel molecular target for the prevention and treatment of head and neck cancer on the advance of basic and preclinical research].
Guo W; Zeng QH; Wang CY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 May; 39(3):261-3. PubMed ID: 15196405
[No Abstract] [Full Text] [Related]
4. [The yin yang of inflammation: inducible and constitutive cyclooxygenase. Nimesulide and selective inhibitors of inducible cyclooxygenase].
Cirino G; Coppini A; Bigini C; Mitchell JA
Eur Rev Med Pharmacol Sci; 1998; 2(3 Suppl 1):1-8. PubMed ID: 10887524
[No Abstract] [Full Text] [Related]
5. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
6. COX-2: a target for prevention and treatment of esophageal cancer.
Altorki N
J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
[No Abstract] [Full Text] [Related]
7. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
8. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.
Mohammed SI; Bennett PF; Craig BA; Glickman NW; Mutsaers AJ; Snyder PW; Widmer WR; DeGortari AE; Bonney PL; Knapp DW
Cancer Res; 2002 Jan; 62(2):356-8. PubMed ID: 11809678
[TBL] [Abstract][Full Text] [Related]
9. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
10. Why cyclooxygenase-2 inhibition plus chemotherapy?
Sweeney CJ
Am J Clin Oncol; 2003 Aug; 26(4):S122-5. PubMed ID: 12902869
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.
Lin DT; Subbaramaiah K; Shah JP; Dannenberg AJ; Boyle JO
Head Neck; 2002 Aug; 24(8):792-9. PubMed ID: 12203806
[TBL] [Abstract][Full Text] [Related]
12. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Suppl 2():S59-60. PubMed ID: 15899628
[No Abstract] [Full Text] [Related]
13. [Safe use of anti-inflammatory analgesics].
Finnish Society of Gastroenterology and the Task force of Finnish Rheumatological Society
Duodecim; 2003; 119(22):2167-71. PubMed ID: 14702803
[No Abstract] [Full Text] [Related]
14. COX-2: a molecular target for colorectal cancer prevention.
Brown JR; DuBois RN
J Clin Oncol; 2005 Apr; 23(12):2840-55. PubMed ID: 15837998
[TBL] [Abstract][Full Text] [Related]
15. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Suppl 2():S89-98. PubMed ID: 15899632
[TBL] [Abstract][Full Text] [Related]
16. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
Amir M; Agarwal HK
Pharmazie; 2005 Aug; 60(8):563-70. PubMed ID: 16124396
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inhibitors in lung cancer.
Ramalingam S; Belani CP
Clin Lung Cancer; 2004 Jan; 5(4):245-53. PubMed ID: 14967078
[TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibitors and other NSAIDs in bladder and prostate cancer.
Sabichi AL; Lippman SM
Prog Exp Tumor Res; 2003; 37():163-78. PubMed ID: 12795054
[No Abstract] [Full Text] [Related]
19. Cancer prevention: a new era beyond cyclooxygenase-2.
Rigas B; Kashfi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):1-8. PubMed ID: 15805430
[TBL] [Abstract][Full Text] [Related]
20. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers].
Eschwege P
Bull Cancer; 2004 May; 91 Spec No():S113-6. PubMed ID: 15239339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
